Aktiesnakken — December 2020
-
more on Regeneron pauses studies of a key cancer drug, citing safety concerns - https://www.biopharmadive.com/news/regeneron-pause-enrollment-lymphoma-drug/592209/
-
Holger Zschaepitz
@Schuldensuehner
·
1 t
US labels #Switzerland as a currency manipulator as SNB balance sheet has risen by almost 13% YTD.https://twitter.com/Schuldensuehner/status/1339203185152577537/photo/1 -
God morgen fra K!
-
Investeringspocasten: Grønt er blevet big business: https://www.proinvestor.com/index.php?p=debat_1&postid=89307
-
God formiddag
-
-
Ditto her. Tror det er en fejl.
-
Det ser ikke ud som om der er nogen nævneværdig rotation væk fra tech-aktier til værdi aktier endnu https://www.tradingview.com/x/smC7NcsZ/ gad vide om de nogensinde kommer til at outperforme værdi aktier igen ... jeg tror det ikke, fordi https://sparklinecapital.files.wordpress.com/2020/11/sparkline-intangibles.pdf
-
God morgen.
-
-
JimJul, den handler om tildeling af warrants
-
(PLX AI) – Pandora guidance upgrades have more than tripled the company's share price from the lows earlier this year, and analysts believe the jewelry maker will raise its forecast for 2020 one more time in early January. <br/>• We see a high likelihood of Pandora beating its 2020 guidance and we now forecast Q4 EBIT 13% ahead of the company-collected consensus, Nordea said<br/>• We think a favorable trading update is likely in early January: Nordea<br/>• We expect good momentum in Q4 leading
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind